Merck and a woman suing the drugmaker agreed to halt a trial over alleged injuries from the drugmaker's human papillomavirus ...

By Dan Levine, Mike Spector (Reuters) -Merck and a woman suing the drugmaker agreed to halt a trial over alleged injuries ...

Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new ...

The global Microcarriers market, valued at US$2.03 billion in 2023, is forecasted to grow at a robust CAGR of 8.0%, reaching US$2.08 billion ...

Merck's 2025 revenue forecast fell short of Wall Street expectations, following the company's decision to temporarily halt shipments of its cancer vaccine, Gardasil, to China, CNBC reported Feb. 4.

Merck swung to a quarterly profit as sales grew to beat Wall Street's estimates, though the drug company's outlook for 2025 and a slide in sales of its HPV vaccine, Gardasil, hit shares. The ...

Merck on Tuesday issued full-year 2025 revenue guidance that fell short of Wall Street's expectations. The company said that sales range reflects a decision to halt shipments of Gardasil, a ...

Merck (MRK) is down -10.8%, or -$10.74 to $89.05. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing ...

The January transfer window has come to a close and while every league isn't done with moves, the major European ones are. It has been a busy winter for Americans with not only moves around Major ...